Sep 1, 2026 09:07AM
Aug 30, 2026 11:30AM
Aug 30, 2026 11:30AM
Aug 24, 2026 07:30AM
Aug 4, 2026 04:01PM
Aug 4, 2026 04:00PM
Aug 4, 2026 04:00PM Arrowhead Pharmaceuticals buys FDA priority review voucher for plozasiran
Aug 4, 2026 04:00PM
Jul 27, 2026 06:47AM
Jul 22, 2026 07:30AM
Jul 22, 2026 07:30AM
Jun 22, 2026 12:36PM
Jun 22, 2026 12:33PM
May 26, 2026 10:00AM Arrowhead presents plozasiran data supporting use without dose adjustment
May 26, 2026 10:00AM
May 7, 2026 04:01PM
May 1, 2026 07:30AM
May 1, 2026 07:30AM
Apr 24, 2026 06:39AM
Apr 24, 2026 06:39AM
Mar 30, 2026 04:21AM Arrowhead presents long-term plozasiran data for hypertriglyceridemia
Mar 28, 2026 10:30AM
Mar 26, 2026 02:33PM
Feb 17, 2026 08:30AM
Feb 5, 2026 04:05PM
Jan 7, 2026 07:32AM
Jan 7, 2026 07:30AM
Jan 5, 2026 07:30AM Health Canada approves Arrowhead's REDEMPLO for rare triglyceride disorder
Jan 5, 2026 07:30AM
Dec 22, 2025 07:06AM
Dec 21, 2025 04:00AM
Dec 19, 2025 09:06AM
Dec 2, 2025 07:30AM
Dec 2, 2025 07:30AM
Nov 25, 2025 04:00PM Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results
Nov 19, 2025 09:14AM
Nov 19, 2025 09:06AM
Nov 19, 2025 08:51AM
Nov 18, 2025 11:52AM
Nov 18, 2025 11:52AM
Nov 18, 2025 11:17AM
Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
Sep 11, 2025 07:30AM
Sep 11, 2025 07:30AM
Aug 7, 2025 04:01PM
Aug 1, 2025 06:30AM
Aug 1, 2025 06:30AM
Jun 23, 2025 07:30AM
May 13, 2025 04:52AM Arrowhead Pharma (ARWR) PT Lowered to $17 at Citi
May 12, 2025 04:01PM

330,179 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All